RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $5,170,000 | +16577.4% | 576,319 | +9914.2% | 0.00% | – |
| Q2 2016 | $31,000 | -67.7% | 5,755 | -72.3% | 0.00% | – |
| Q1 2016 | $96,000 | -87.8% | 20,748 | -86.3% | 0.00% | – |
| Q4 2015 | $784,000 | +0.8% | 150,916 | +17.4% | 0.00% | – |
| Q3 2015 | $778,000 | -78.2% | 128,581 | -43.2% | 0.00% | -100.0% |
| Q2 2015 | $3,572,000 | +114.9% | 226,194 | +48.0% | 0.00% | 0.0% |
| Q1 2015 | $1,662,000 | +30.6% | 152,866 | +26.4% | 0.00% | – |
| Q4 2014 | $1,273,000 | -40.6% | 120,940 | -45.9% | 0.00% | -100.0% |
| Q3 2014 | $2,142,000 | -38.4% | 223,395 | -25.9% | 0.00% | 0.0% |
| Q2 2014 | $3,480,000 | +124.8% | 301,279 | +94.5% | 0.00% | 0.0% |
| Q1 2014 | $1,548,000 | +366.3% | 154,868 | +509.0% | 0.00% | – |
| Q4 2013 | $332,000 | +0.9% | 25,429 | +15.2% | 0.00% | – |
| Q3 2013 | $329,000 | +140.1% | 22,066 | +50.4% | 0.00% | – |
| Q2 2013 | $137,000 | – | 14,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |